Patent details
EP3551652 Title: GLP-1/GLP-2 DUAL AGONISTS
Basic Information
- Publication number:
- EP3551652
- PCT Application Number:
- EP2017082289
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP178324810
- PCT Publication Number:
- WO2018104560
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- GLP-1/GLP-2 DUAL AGONISTS
- French Title of Invention:
- AGONISTES DOUBLES DE GLP-1/GLP-2
- German Title of Invention:
- DUALE GLP-1/GLP-2-AGONISTEN
- SPC Number:
Dates
- Filing date:
- 11/12/2017
- Grant date:
- 20/01/2021
- EP Publication Date:
- 16/10/2019
- PCT Publication Date:
- 14/06/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 20/01/2021
- EP B1 Publication Date:
- 20/01/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 11/12/2021
- Expiration date:
- 11/12/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 13/01/2021
- Name:
- Zealand Pharma A/S
- Address:
- Sydmarken 11, 2860 Søborg, Denmark (DK)
Inventor
1
- Name:
- GIEHM, Lise
- Address:
- Denmark (DK)
2
- Name:
- DUE LARSEN, Bjarne
- Address:
- Denmark (DK)
3
- Name:
- EDWARDS, Alistair Vincent Gordon
- Address:
- Denmark (DK)
Priority
- Priority Number:
- PA201600756
- Priority Date:
- 09/12/2016
- Priority Country:
- Denmark (DK)
Classification
- IPC classification:
- A61K 38/26; C07K 14/605;
Publication
European Patent Bulletin
- Issue number:
- 202103
- Publication date:
- 20/01/2021
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|